LifeMD authorized a cash dividend of $0.5546875 per share for its Series A Preferred Stock, payable January 15, 2025.
Quiver AI Summary
LifeMD, Inc. has announced a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, which will be paid on January 15, 2025, to shareholders recorded by the end of January 3, 2025. LifeMD is a provider of virtual primary care services, offering telemedicine, lab and pharmacy access, and specialized treatments for over 200 conditions through a robust digital care platform and a large affiliated medical group. The announcement also includes cautionary notes about forward-looking statements, emphasizing that actual results may vary due to various risks and uncertainties.
Potential Positives
- The announcement of a cash dividend signals strong financial health and a commitment to returning value to shareholders.
- The dividend payment date and record date provide clear communication for investors, promoting trust and transparency.
- LifeMD’s positioning as a leading provider of virtual primary care services may enhance investor confidence in its growth potential and sustainable business model.
Potential Negatives
- The announcement of a cash dividend may signal financial pressures or liquidity concerns, as companies typically only issue dividends when they have sufficient cash flow and profitability.
- The emphasis on forward-looking statements and associated risks may raise concerns among investors about the company's future performance and its ability to meet its projections, particularly given market uncertainties.
- The press release includes a cautionary note about risks and uncertainties that could materially affect actual results, which may create apprehension regarding the stability or growth prospects of the company.
FAQ
What is the dividend amount announced by LifeMD?
LifeMD has announced a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock.
When will the dividend be paid by LifeMD?
The dividend will be paid on January 15, 2025, to holders of record at close of business on January 3, 2025.
What services does LifeMD provide?
LifeMD provides virtual primary care, including telemedicine, laboratory access, pharmacy services, and specialized treatment for over 200 conditions.
How can I learn more about LifeMD?
For more information about LifeMD and its offerings, visit their website at LifeMD.com.
What should investors know about forward-looking statements?
Forward-looking statements involve risks and uncertainties that may cause actual results to differ from current expectations. Refer to SEC filings for details.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFMD Insider Trading Activity
$LFMD insiders have traded $LFMD stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LFMD stock by insiders over the last 6 months:
- JUSTIN SCHREIBER (Chief Executive Officer) sold 25,000 shares.
- STEFAN GALLUPPI (Chief Innovation Officer) purchased 3,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFMD Hedge Fund Activity
We have seen 53 institutional investors add shares of $LFMD stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 687,280 shares (+inf%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 664,329 shares (+719.5%) to their portfolio in Q3 2024
- EAM INVESTORS, LLC removed 411,610 shares (-100.0%) from their portfolio in Q2 2024
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 347,455 shares (-63.0%) from their portfolio in Q3 2024
- G2 INVESTMENT PARTNERS MANAGEMENT LLC removed 305,000 shares (-100.0%) from their portfolio in Q3 2024
- MORGAN STANLEY removed 287,843 shares (-45.9%) from their portfolio in Q3 2024
- LAURION CAPITAL MANAGEMENT LP removed 285,637 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
The preferred dividend will be paid on January 15, 2025, to holders of record at the close of business on January 3, 2025.
About LifeMD, Inc.
LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com .
Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
Investor Contact
Marc Benathen, Chief Financial Officer
[email protected]
Media Contact
Jessica Friedeman, Chief Marketing Officer
[email protected]